chr11-67991572-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_030930.4(UNC93B1):c.1768G>T(p.Gly590Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00449 in 1,488,914 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G590R) has been classified as Uncertain significance.
Frequency
Consequence
NM_030930.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UNC93B1 | NM_030930.4 | c.1768G>T | p.Gly590Trp | missense_variant | 11/11 | ENST00000227471.7 | |
UNC93B1 | XM_011545290.1 | c.1357G>T | p.Gly453Trp | missense_variant | 9/9 | ||
UNC93B1 | XM_011545291.3 | c.1213G>T | p.Gly405Trp | missense_variant | 8/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UNC93B1 | ENST00000227471.7 | c.1768G>T | p.Gly590Trp | missense_variant | 11/11 | 1 | NM_030930.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00887 AC: 1347AN: 151940Hom.: 12 Cov.: 33
GnomAD3 exomes AF: 0.00290 AC: 269AN: 92742Hom.: 2 AF XY: 0.00255 AC XY: 132AN XY: 51842
GnomAD4 exome AF: 0.00399 AC: 5336AN: 1336858Hom.: 27 Cov.: 30 AF XY: 0.00389 AC XY: 2557AN XY: 658162
GnomAD4 genome AF: 0.00888 AC: 1351AN: 152056Hom.: 12 Cov.: 33 AF XY: 0.00877 AC XY: 652AN XY: 74344
ClinVar
Submissions by phenotype
Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at